Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib plus Gemcitabine and Cisplatin in Bladder Cancer
NCT01215266Phase 2Terminated
- Sponsor
- Society of Urologic Oncology
- Start
- Oct 2006
- Primary completion
- Jun 2011
01
Overview
A Phase 2 trial of sorafenib in urothelial carcinoma (UC), sponsored by Society of Urologic Oncology. Started Oct 2006; status: terminated.
02
Drugs
sorafenib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01215266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215266.